Want to see HK:2575 full AI Analyst Report?

Xuanzhu Biopharmaceutical Co., Ltd. Class H (2575) Cash flow

2 Followers

Xuanzhu Biopharmaceutical Co., Ltd. Class H Cash Flow

HK:2575's free cash flow for Q2 2026 was HK$-59.31M. For the 2026 fiscal year, HK:2575's free cash flow was decreased by HK$-118.38M and operating cash flow was HK$-59.17M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	HK$ -222.97M	HK$ -104.67M	HK$ -128.13M	HK$ -449.15M	HK$ -504.75M
Investing Cash Flow	HK$ 121.20M	HK$ 143.04M	HK$ 49.43M	HK$ -579.14M	HK$ 59.83M
Financing Cash Flow	HK$ 675.14M	HK$ -13.47M	HK$ -10.94M	HK$ -14.14M	HK$ 1.05B
End Cash Position	HK$ 765.43M	HK$ 176.45M	HK$ 157.32M	HK$ 251.62M	HK$ 1.37B
Free Cash Flow	HK$ -223.60M	HK$ -105.22M	HK$ -130.05M	HK$ -501.15M	HK$ -597.99M

Currency in HKD